Evoke Pharma
EVOK
EVOK
10 hedge funds and large institutions have $3.29M invested in Evoke Pharma in 2014 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
10
Holders Change
–
Holders Change %
0%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
TC
1
TFS Capital
West Chester,
Pennsylvania
|
$0 |
| 2 |
2
Citigroup
New York
|
$0 |
| 3 |
U
3
UBS
Zurich,
Switzerland
|
$6K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
OM
1
Opaleye Management
Boston,
Massachusetts
| $1.96M | 242,500 | +9,100 | +4% |
|
|
SC
2
Sophrosyne Capital
New York
| $397K | 49,000 | – | – |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $378K | 48,394 | +1,000 | +2% |
|
4
Bank of America
Charlotte,
North Carolina
| $271K | 33,500 | – | – |
|
|
LP
5
LMR Partners
London,
United Kingdom
| $187K | 23,882 | – | – |
|
6
Geode Capital Management
Boston,
Massachusetts
| $80K | 10,276 | – | – |
|
|
U
7
UBS
Zurich,
Switzerland
| $6K | 727 | -593 | -45% |
|
8
Morgan Stanley
New York
| $4K | 500 | – | – |
|
|
BIM
9
BlackRock Investment Management
Wilmington,
Delaware
| $4K | 489 | +489 | New |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $1K | 84 | +84 | New |
|
|
TC
11
TFS Capital
West Chester,
Pennsylvania
| – | – | -10,556 | Closed |
|
|
12
Citigroup
New York
| – | – | -2,086 | Closed |
|